Leaderna Therapeutics

Chengdu, China · Founded 2022 · Privately Held (backing)

Developer of nucleic acid-based therapeutic research designed to advance targeted biological interventions. Leaderna Therapeutics is based in Chengdu, China and was founded in 2022. Its last reported valuation was $33.9 million in Dec 2022. It has raised $44.9 million.

Last reported valuation

$33.9M

Oct 2026

Priced at

—

Total raised

$44.9M

Last round

—

How much has Leaderna Therapeutics raised?

$44.9Macross 0 recorded rounds

Free account

More of Leaderna Therapeutics with a free account

·The complete investor list: 14 names
·Watch Leaderna Therapeutics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Leaderna Therapeutics investors

14 investors are on record for Leaderna Therapeutics, including CAS Star, CDH Investments, Sky9 Capital and Chengdu Venture Capital Group.

For fundraisers

Raising for a company like Leaderna Therapeutics?

14 investors have backed Leaderna Therapeutics.

See all 14 investors →

Frequently asked about Leaderna Therapeutics

How much has Leaderna Therapeutics raised?: Leaderna Therapeutics has raised $44.9M in total across 0 recorded funding rounds.